Literature DB >> 20581454

Impact of the hypoxic tumor microenvironment on the regulation of cancer stem cell characteristics.

Qun Lin1, Zhong Yun.   

Abstract

Solid tumors often contain regions with insufficient oxygen delivery, a condition called hypoxia. Tumor hypoxia is an independent prognostic factor significantly correlated with advanced stages of malignancy, increased resistance to conventional therapy, and reduced disease-free survival. Hypoxic tumor cells exhibit poorly differentiated phenotypes resembling stem or progenitor cells. Studies have shown that hypoxia can inhibit tumor cell differentiation and promote maintenance of cancer stem cells. In addition, hypoxia also blocks the differentiation of mesenchymal stem/progenitor cells, a potential source of tumor-associated stromal cells. Therefore, hypoxia may play a critical role during the evolution of the tumor stromal microenvironment and formation of the putative cancer stem cell niches. Conceptually, hypoxia may help create a microenvironment enriched both in poorly differentiated tumor cells and in undifferentiated stromal cells. Such an undifferentiated hypoxic microenvironment may provide essential cellular interactions and environmental signals for the preferential maintenance of cancer stem cells. This review will discuss the hypoxia-regulated stem cell pathways and their roles in the maintenance of cancer stem cell functions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20581454      PMCID: PMC3637993          DOI: 10.4161/cbt.9.12.12347

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  130 in total

Review 1.  Hypoxia in cancer: significance and impact on clinical outcome.

Authors:  Peter Vaupel; Arnulf Mayer
Journal:  Cancer Metastasis Rev       Date:  2007-06       Impact factor: 9.264

2.  Adaptive myogenesis under hypoxia.

Authors:  Zhong Yun; Qun Lin; Amato J Giaccia
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

3.  A new role for hypoxia in tumor progression: induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs.

Authors:  A Coquelle; F Toledo; S Stern; A Bieth; M Debatisse
Journal:  Mol Cell       Date:  1998-08       Impact factor: 17.970

4.  FA1 immunoreactivity in endocrine tumours and during development of the human fetal pancreas; negative correlation with glucagon expression.

Authors:  D Tornehave; C H Jensen; B Teisner; L I Larsson
Journal:  Histochem Cell Biol       Date:  1996-12       Impact factor: 4.304

5.  CXCR4 regulates growth of both primary and metastatic breast cancer.

Authors:  Matthew C P Smith; Kathryn E Luker; Joel R Garbow; Julie L Prior; Erin Jackson; David Piwnica-Worms; Gary D Luker
Journal:  Cancer Res       Date:  2004-12-01       Impact factor: 12.701

6.  Establishing a germ cell origin for metastatic tumors using OCT4 immunohistochemistry.

Authors:  Liang Cheng
Journal:  Cancer       Date:  2004-11-01       Impact factor: 6.860

7.  Identification of pancreatic cancer stem cells.

Authors:  Chenwei Li; David G Heidt; Piero Dalerba; Charles F Burant; Lanjing Zhang; Volkan Adsay; Max Wicha; Michael F Clarke; Diane M Simeone
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

8.  Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1.

Authors:  Daniel J Ceradini; Anita R Kulkarni; Matthew J Callaghan; Oren M Tepper; Nicholas Bastidas; Mark E Kleinman; Jennifer M Capla; Robert D Galiano; Jamie P Levine; Geoffrey C Gurtner
Journal:  Nat Med       Date:  2004-07-04       Impact factor: 53.440

Review 9.  Development of HIF-1 inhibitors for cancer therapy.

Authors:  Barbara Onnis; Annamaria Rapisarda; Giovanni Melillo
Journal:  J Cell Mol Med       Date:  2009-08-08       Impact factor: 5.310

10.  Stra13 regulates satellite cell activation by antagonizing Notch signaling.

Authors:  Hong Sun; Li Li; Cécile Vercherat; Neriman Tuba Gulbagci; Sujata Acharjee; Jiali Li; Teng-Kai Chung; Tin Htwe Thin; Reshma Taneja
Journal:  J Cell Biol       Date:  2007-05-14       Impact factor: 10.539

View more
  43 in total

1.  DLK1, delta-like 1 homolog (Drosophila), regulates tumor cell differentiation in vivo.

Authors:  Asma Begum; Yuri Kim; Qun Lin; Zhong Yun
Journal:  Cancer Lett       Date:  2011-12-03       Impact factor: 8.679

Review 2.  Autophagy in stem and progenitor cells.

Authors:  Carlo Rodolfo; Sabrina Di Bartolomeo; Francesco Cecconi
Journal:  Cell Mol Life Sci       Date:  2015-10-26       Impact factor: 9.261

Review 3.  Cellular and molecular mechanisms underlying oxygen-dependent radiosensitivity.

Authors:  Chao Liu; Qun Lin; Zhong Yun
Journal:  Radiat Res       Date:  2015-05-04       Impact factor: 2.841

Review 4.  Crosstalk between cancer cells and blood endothelial and lymphatic endothelial cells in tumour and organ microenvironment.

Authors:  Esak Lee; Niranjan B Pandey; Aleksander S Popel
Journal:  Expert Rev Mol Med       Date:  2015-01-30       Impact factor: 5.600

5.  Hypoxia induces IGFBP3 in esophageal squamous cancer cells through HIF-1α-mediated mRNA transcription and continuous protein synthesis.

Authors:  Mitsuteru Natsuizaka; Seiji Naganuma; Shingo Kagawa; Shinya Ohashi; Azal Ahmadi; Harry Subramanian; Sanders Chang; Kei J Nakagawa; Xinjun Ji; Stephen A Liebhaber; Andres J Klein-Szanto; Hiroshi Nakagawa
Journal:  FASEB J       Date:  2012-03-13       Impact factor: 5.191

6.  Hypoxia-activated cytotoxicity of benznidazole against clonogenic tumor cells.

Authors:  Quhuan Li; Qun Lin; Zhong Yun
Journal:  Cancer Biol Ther       Date:  2016-10-27       Impact factor: 4.742

7.  The anti-protozoan drug nifurtimox preferentially inhibits clonogenic tumor cells under hypoxic conditions.

Authors:  Quhuan Li; Qun Lin; Hoon Kim; Zhong Yun
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

Review 8.  Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer.

Authors:  S Chouaib; M Z Noman; K Kosmatopoulos; M A Curran
Journal:  Oncogene       Date:  2016-06-27       Impact factor: 9.867

9.  Logic Learning Machine creates explicit and stable rules stratifying neuroblastoma patients.

Authors:  Davide Cangelosi; Fabiola Blengio; Rogier Versteeg; Angelika Eggert; Alberto Garaventa; Claudio Gambini; Massimo Conte; Alessandra Eva; Marco Muselli; Luigi Varesio
Journal:  BMC Bioinformatics       Date:  2013-04-22       Impact factor: 3.169

10.  Changes in the frequencies of human hematopoietic stem and progenitor cells with age and site.

Authors:  Tracy L Farrell; Timothy R McGuire; Laura D Bilek; Susan K Brusnahan; John D Jackson; Judy T Lane; Kevin L Garvin; Barbara J O'Kane; Ann M Berger; Sonal R Tuljapurkar; M Anne Kessinger; John Graham Sharp
Journal:  Exp Hematol       Date:  2013-11-15       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.